NO954660L - Tilberedninger i form av faste lösninger - Google Patents

Tilberedninger i form av faste lösninger

Info

Publication number
NO954660L
NO954660L NO954660A NO954660A NO954660L NO 954660 L NO954660 L NO 954660L NO 954660 A NO954660 A NO 954660A NO 954660 A NO954660 A NO 954660A NO 954660 L NO954660 L NO 954660L
Authority
NO
Norway
Prior art keywords
pct
solid solutions
date nov
preparations
sec
Prior art date
Application number
NO954660A
Other languages
English (en)
Norwegian (no)
Other versions
NO954660D0 (no
Inventor
Sven Grabowski
Winfried Mueller
Joerg Rosenberg
Rudolf Binder
Axel Sanner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO954660D0 publication Critical patent/NO954660D0/no
Publication of NO954660L publication Critical patent/NO954660L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cephalosporin Compounds (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO954660A 1993-05-18 1995-11-17 Tilberedninger i form av faste lösninger NO954660L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4316537A DE4316537A1 (de) 1993-05-18 1993-05-18 Zubereitungen in Form fester Lösungen
PCT/EP1994/001489 WO1994026267A1 (de) 1993-05-18 1994-05-09 Zubereitungen in form fester lösungen

Publications (2)

Publication Number Publication Date
NO954660D0 NO954660D0 (no) 1995-11-17
NO954660L true NO954660L (no) 1995-11-17

Family

ID=6488330

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954660A NO954660L (no) 1993-05-18 1995-11-17 Tilberedninger i form av faste lösninger

Country Status (23)

Country Link
US (1) US5684040A (da)
EP (1) EP0697867B1 (da)
JP (1) JPH08510219A (da)
KR (1) KR960702305A (da)
CN (1) CN1123524A (da)
AT (1) ATE209913T1 (da)
AU (1) AU688328B2 (da)
BR (1) BR9406414A (da)
CA (1) CA2163255A1 (da)
CZ (1) CZ300895A3 (da)
DE (2) DE4316537A1 (da)
DK (1) DK0697867T3 (da)
ES (1) ES2169073T3 (da)
FI (1) FI955524A7 (da)
HR (1) HRP940305A2 (da)
HU (1) HUT73657A (da)
IL (1) IL109532A (da)
NO (1) NO954660L (da)
NZ (1) NZ267080A (da)
PL (1) PL311698A1 (da)
SI (1) SI9420035A (da)
WO (1) WO1994026267A1 (da)
ZA (1) ZA943368B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
WO2002024168A1 (fr) * 2000-09-25 2002-03-28 Nippon Shinyaku Co., Ltd. Procede de production d'une dispersion solide medicinale
TNSN03137A1 (en) * 2001-06-22 2005-12-23 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS COMPRISING LOW SOLUBILITY AND / OR ACID SENSITIVE DRUGS AND NEUTRALIZED ACID POLYMERS.
JP2004534812A (ja) * 2001-06-22 2004-11-18 ファイザー・プロダクツ・インク 薬物および中性ポリマーの分散物の医薬組成物
CA2450748A1 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
US20040015519A1 (en) * 2001-10-15 2004-01-22 Yukitoshi Maeda Content delivery server and content delivery system having the same
CN1625397A (zh) 2002-02-01 2005-06-08 辉瑞产品公司 胆固醇酯转移蛋白抑制剂的控制释放药物剂型
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
EP1530457B1 (en) * 2002-08-12 2009-09-09 Bend Research, Inc. Pharmaceutical compositions of drugs in semi-ordered form and polymers
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
EP1650200A4 (en) * 2003-07-11 2008-03-19 Osaka Ind Promotion Org SULPHONATE COMPOUND AND FLUORESCENCE ENCODER USING THIS
WO2005005401A1 (ja) * 2003-07-11 2005-01-20 Osaka Industrial Promotion Organization スルホン酸エステル化合物およびそれを用いた蛍光プローブ
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS5446837A (en) * 1977-09-19 1979-04-13 Kanebo Ltd Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
BE880713A (fr) * 1978-12-21 1980-06-19 Sandoz Sa Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンa物質含有易溶性固形製剤
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JP2636265B2 (ja) * 1987-10-06 1997-07-30 萬有製薬株式会社 脳循環改善剤
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
DE3834860A1 (de) * 1988-10-13 1990-04-19 Basf Ag Heterocyclisch substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
DE4316537A1 (de) 1994-11-24
DK0697867T3 (da) 2002-03-11
FI955524L (fi) 1995-11-16
FI955524A0 (fi) 1995-11-16
ZA943368B (en) 1995-11-17
BR9406414A (pt) 1995-12-19
HRP940305A2 (en) 1996-12-31
NZ267080A (en) 1996-11-26
ES2169073T3 (es) 2002-07-01
SI9420035A (en) 1996-06-30
EP0697867B1 (de) 2001-12-05
DE59409994D1 (de) 2002-01-17
CZ300895A3 (en) 1996-02-14
CA2163255A1 (en) 1994-11-24
AU688328B2 (en) 1998-03-12
IL109532A (en) 1997-11-20
NO954660D0 (no) 1995-11-17
ATE209913T1 (de) 2001-12-15
HU9503296D0 (en) 1996-01-29
PL311698A1 (en) 1996-03-04
US5684040A (en) 1997-11-04
HUT73657A (en) 1996-09-30
EP0697867A1 (de) 1996-02-28
JPH08510219A (ja) 1996-10-29
AU6926394A (en) 1994-12-12
IL109532A0 (en) 1994-08-26
CN1123524A (zh) 1996-05-29
WO1994026267A1 (de) 1994-11-24
FI955524A7 (fi) 1995-11-16
KR960702305A (ko) 1996-04-27

Similar Documents

Publication Publication Date Title
NO954660D0 (no) Tilberedninger i form av faste lösninger
TR199801179T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
FI852995A0 (fi) Stabila salter av polyanioner innehaollande s-adenosyl-l-methionin (sam).
IL137882A0 (en) Nanoparticles comprising at least one polymer and at least one compound able to complex one or more active ingredients
DE69837339D1 (de) Veränderung der Wirkstoffladung in multivesikulären Liposomen
IE873125L (en) Benzimidazole derivatives
CA2247848A1 (en) Nitric oxide donors capable of reducing toxicity from drugs
ES8801217A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
CA2022177A1 (en) Arginine deiminase, its manufacturing method, and an anti-cancer agent containing this enzyme as an effective ingredient
ZA909124B (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
TR199901274T2 (xx) Farnezil protein transferaz inhibit�rleri olarak yararl� yeni trisiklik piperidinil bile�ikleri
DK1056771T3 (da) Streptograminderivater, deres fremstilling og præparater, der indeholder dem
NO980058L (no) Opthalmiske preparater
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
IE870845L (en) N'-substituted-n,n'-diacylhydrazines
DK0742214T3 (da) I hjerte-kar-systemet aktive, nye seco-D steroider samt farmaceutiske præparater indeholdende sådanne
IE890748L (en) Peptides with pharmaceutical activity
AU6878900A (en) 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof
EP0462291A4 (en) Acat enzyme inhibiting composition
GR970100096A (el) Εξωτερικη διαταξη κατα των παρασιτων για βοοειδη με βαση τη ν-φαινυλπυραζολη, ειδικα σκουλαρικια.
AU3138489A (en) Peptides with pharmaceutical activity
CA2293713A1 (en) Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
UA6524A (uk) Засіб боротьби з вірусами рослин

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application